FMN vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
FMN exhibits a strong Piotroski F-Score of 7/9, indicating solid short-term operational health, but this is overshadowed by severe valuation and sustainability issues. The current price of $11.15 trades at a massive premium to both the Graham Number ($5.81) and the Intrinsic Value ($0.84), while a P/E of 92.92 is unjustifiable given negative revenue growth of -22.30%. Most critically, the dividend payout ratio of 425% is unsustainable, suggesting the fund is returning capital rather than earnings. Despite a healthy Price/Book ratio of 0.89, the combination of bearish technicals and declining fundamentals warrants a bearish outlook.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
FMN vs JPM: Head-to-Head Comparison
This page compares Federated Hermes Premier Municipal Income Fund (FMN) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.